SPONSOR
Shenzhen Ionova Life Sciences Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 1, Phase 2
Conditions studied: CancerSolid Tumor, AdultCancer MetastaticSolid CarcinomaSolid Tumor, Unspecified, AdultTumor, SolidAdvanced Metastatic Castration Resistant Prostate Cancer
NCT04443088 Phase 1
Recruiting
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Cancer
NCT06609005 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Advanced Metastatic Castration Resistant Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology